Emerald Health Therapeutics Stock Net Income
Fundamental analysis of Emerald Health allows traders to better anticipate movements in Emerald Health's stock price by examining its financial health and performance throughout various phases of its business cycle.
Emerald |
Emerald Health Therapeutics OTC Stock Net Income Analysis
Emerald Health's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Emerald Health Net Income | (39.41 M) |
Most of Emerald Health's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Emerald Health Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Emerald Health Therapeutics reported net income of (39.41 Million). This is 111.55% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 106.9% higher than that of the company.
Emerald Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Emerald Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Emerald Health could also be used in its relative valuation, which is a method of valuing Emerald Health by comparing valuation metrics of similar companies.Emerald Health is currently under evaluation in net income category among its peers.
Emerald Fundamentals
| Return On Equity | -0.67 | |||
| Return On Asset | -0.22 | |||
| Operating Margin | (2.48) % | |||
| Current Valuation | (5.84 M) | |||
| Shares Outstanding | 213.47 M | |||
| Shares Owned By Insiders | 1.73 % | |||
| Price To Earning | (20.19) X | |||
| Price To Book | 0.41 X | |||
| Price To Sales | 1.21 X | |||
| Revenue | 9.68 M | |||
| Gross Profit | (6.45 M) | |||
| EBITDA | (35.61 M) | |||
| Net Income | (39.41 M) | |||
| Cash And Equivalents | 15.52 M | |||
| Cash Per Share | 0.07 X | |||
| Total Debt | 40 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 2.98 X | |||
| Book Value Per Share | 0.13 X | |||
| Cash Flow From Operations | (17.11 M) | |||
| Earnings Per Share | (0.12) X | |||
| Number Of Employees | 15 | |||
| Beta | 0.63 | |||
| Market Capitalization | 8.65 M | |||
| Total Asset | 40.89 M | |||
| Z Score | 21.0 | |||
| Net Asset | 40.89 M |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Emerald OTC Stock
If you are still planning to invest in Emerald Health Thera check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Emerald Health's history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges |